Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies
This study is ongoing, but not recruiting participants.
Sponsor:
University of Pittsburgh
Collaborator:
Bristol-Myers Squibb
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00388427
First received: October 13, 2006
Last updated: June 28, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2012 |
| Primary Completion Date: | July 2009 (Final data collection date for primary outcome measure) |